228 related articles for article (PubMed ID: 18366613)
21. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
Enberg U; Farnebo LO; Wedell A; Gröndal S; Thorén M; Grimelius L; Kjellman M; Bäckdahl M; Hamberger B
World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
[TBL] [Abstract][Full Text] [Related]
22. Functional adrenal cortical tumors in pediatric patients: a clinicopathologic and immunohistochemical study of a long term follow-up series.
Bergadá I; Venara M; Maglio S; Ciaccio M; Diez B; Bergadá C; Chemes H
Cancer; 1996 Feb; 77(4):771-7. PubMed ID: 8616771
[TBL] [Abstract][Full Text] [Related]
23. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
[TBL] [Abstract][Full Text] [Related]
24. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.
Arnaldi G; Gasc JM; de Keyzer Y; Raffin-Sanson ML; Perraudin V; Kuhn JM; Raux-Demay MC; Luton JP; Clauser E; Bertagna X
J Clin Endocrinol Metab; 1998 Jun; 83(6):2029-35. PubMed ID: 9626135
[TBL] [Abstract][Full Text] [Related]
25. Surgical management of Cushing's syndrome with emphasis on adrenal autotransplantation.
Hardy JD
Ann Surg; 1978 Sep; 188(3):290-307. PubMed ID: 686895
[TBL] [Abstract][Full Text] [Related]
26. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms.
Gupta D; Shidham V; Holden J; Layfield L
Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):215-21. PubMed ID: 11556748
[TBL] [Abstract][Full Text] [Related]
27. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas.
Liu J; Voutilainen R; Kahri AI; Heikkilä P
J Endocrinol; 1997 Feb; 152(2):175-81. PubMed ID: 9071974
[TBL] [Abstract][Full Text] [Related]
28. [Telomerase expression in various lesions of adrenal cortex].
Mao QZ; Rong S; Fan JH; Ji ZG; Li HZ; Zang MF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):188-9. PubMed ID: 12905801
[TBL] [Abstract][Full Text] [Related]
29. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
30. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
Nomura K; Saito H; Aiba M; Iihara M; Obara T; Takano K
Endocr J; 2003 Apr; 50(2):155-62. PubMed ID: 12803235
[TBL] [Abstract][Full Text] [Related]
31. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
32. p53 protein and its messenger ribonucleic acid in human adrenal tumors.
Adleff V; Rácz K; Tóth M; Varga I; Bezzegh A; Gláz E
J Endocrinol Invest; 1998 Dec; 21(11):753-7. PubMed ID: 9972675
[TBL] [Abstract][Full Text] [Related]
33. Clonal composition of human adrenocortical neoplasms.
Beuschlein F; Reincke M; Karl M; Travis WD; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
Cancer Res; 1994 Sep; 54(18):4927-32. PubMed ID: 7915195
[TBL] [Abstract][Full Text] [Related]
34. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome.
Lefebvre H; Duparc C; Chartrel N; Jegou S; Pellerin A; Laquerriere A; Ivell R; Vaudry H; Kuhn JM
J Clin Endocrinol Metab; 2003 Jul; 88(7):3035-42. PubMed ID: 12843140
[TBL] [Abstract][Full Text] [Related]
35. Adrenocortical neoplasms: role of prognostic markers MIB-1, P53, and RB.
Vargas MP; Vargas HI; Kleiner DE; Merino MJ
Am J Surg Pathol; 1997 May; 21(5):556-62. PubMed ID: 9158680
[TBL] [Abstract][Full Text] [Related]
36. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
[TBL] [Abstract][Full Text] [Related]
37. Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.
Nunes ML; Vattaut S; Corcuff JB; Rault A; Loiseau H; Gatta B; Valli N; Letenneur L; Tabarin A
J Clin Endocrinol Metab; 2009 Feb; 94(2):456-62. PubMed ID: 19001518
[TBL] [Abstract][Full Text] [Related]
38. Cleveland Clinic experience with adrenal Cushing's syndrome.
Daitch JA; Goldfarb DA; Novick AC
J Urol; 1997 Dec; 158(6):2051-5; quiz 2275. PubMed ID: 9366310
[TBL] [Abstract][Full Text] [Related]
39. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.
Giordano TJ; Thomas DG; Kuick R; Lizyness M; Misek DE; Smith AL; Sanders D; Aljundi RT; Gauger PG; Thompson NW; Taylor JM; Hanash SM
Am J Pathol; 2003 Feb; 162(2):521-31. PubMed ID: 12547710
[TBL] [Abstract][Full Text] [Related]
40. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
